CompoAtlas

Gynefam supra allaitement

Food supplement declared in France, declaration No 2022-3-26

Gynefam supra allaitement, from EFFIK, is a food supplement declared in France. Status: withdrawn from the market on 21 March 2025. Main ingredients: Nicotinic acid (vitamin B3), Pantothenic acid (vitamin B5), Biotin (vitamin B8), Calcium, Copper. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
gynefam
Food business operator placing the product on the market
EFFIK
Status
Withdrawn from the market on 21 March 2025
Form
Capsule
Daily dose
2 capsules
Directions for use
Prendre 2 capsules par jour avec un grand verre d'eau
Intended populations
Women
Not recommended (according to the manufacturer)
Taking thyroid medication
Objectives stated by the manufacturer (these are not authorised claims)
Pregnancy and breastfeeding

Declaration 214868, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Huile de poissonnot declared
Taurinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
nicotinic acidNicotinic acid (vitamin B3)10 mg8 mg
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
calcium carbonateCalcium2,500 mg800 mg
calcium salts of orthophosphoric acidCalcium2,500 mg800 mg
cupric sulphateCopper5,000 µg2,000 µg
ferrous bisglycinateIron40 mg (safe level)14 mg
(6S)-5-methyltetrahydrofolic acid, glucosamine saltFolate (vitamin B9)1,000 µg200 µg
potassium iodateIodine600 µg150 µg
sodium seleniteSelenium255 µg50 µg
retinyl palmitateVitamin A3,000 µg d'équivalent rétinol800 µg
thiamin mononitrateVitamin B1 (thiamine)no limit (insufficient data)dose annulled by the French Council of State in 2011
cyanocobalaminVitamin B12no adverse effect defineddose annulled by the French Council of State in 2011
riboflavinVitamin B2 (riboflavin)no limit (insufficient data)dose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg
cholecalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)
DL-alpha-tocopheryl acetateVitamin E300 mg30 mg
zinc oxideZinc25 mg15 mg

Additives

E422, E322, E172, E420

Other ingredients

gélatine, Huile de carthame

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. Déconseillé aux personnes souffrant de troubles de la thyroïde ou de maladies ayant pour conséquence une accumulation anormale de fer. A éviter en cas d'allergie connue à l'un des composants.Consultez votre médecin, votre sage-femme ou votre pharmacien avant de prendre ce complément alimentaire.Complément alimentaire à consommer dans le cadre d'un mode de vie sain. il ne doit pas être utilisé comme substitut d'un régime alimentaire varié et équilibré. Tenir hors de la vue et de la portée des jeunes enfants. A conserver dans un endroit frais et sec, à l'abri de la lumière.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Huile de poisson
    Read the warning, when it applies and the studies cited

    FISH OIL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condition of application: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Health Canada monograph dated 25 September 2026

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : gynefam

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Gynefam supra allaitement: composition and regulation”, https://compoatlas.com/en/supplements/products/214868-gynefam-supra-allaitement, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line